2010 Scrip 100 - Argentina biotech: time to invest?

Argentinian firms have a surprising amount of expertise in the field of biosimilars, while a strong science base has fed healthy demand for locally manufactured products. Can the country elevate its early-stage research efforts to the next level without big pharma's dollars? Francesca Bruce investigates.

Argentinian firms have a surprising amount of expertise in the field of biosimilars, while a strong science base has fed healthy demand for locally manufactured products. Can the country elevate its early-stage research efforts to the next level without big pharma's dollars? Francesca Bruce investigates.

Argentina's biotech sector has a lot to offer companies looking to emerging markets for investment and expansion opportunities. Not only...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anti-infective

More from Therapeutic Category